1-(1Z,9Z-octadecadienyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Term ID

CHEBI:90487

Synonyms

(9Z,17Z,21R)-27-amino-24-hydroxy-24-oxo-19,23,25-trioxa-24lambda(5)-phosphaheptacosa-9,17-dien-21-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
PE P-18:1/22:6
PE(18:1p/22:6)
PE(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Definition

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z,9Z)-octadecadienyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

HMDB:HMDB0011460
LIPID_MAPS_instance:LMGP02030006

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine

1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 1-(1Z,9Z-octadecadienyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Phenotype where environments contain 1-(1Z,9Z-octadecadienyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Phenotype modified by environments containing 1-(1Z,9Z-octadecadienyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Human Disease Model